Mari Dallas
Clinical trials sponsored by Mari Dallas, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Experimental T-Cell therapy targets CMV in transplant patients Results expected Aug 2027 (estimated)
-
Can donor t cells beat a tough virus after transplant? new trial aims to find out.
Disease control Recruiting nowThis early-stage study tests whether infusing virus-fighting T cells from a donor can help stem cell transplant patients overcome a stubborn adenovirus infection. About 20 participants will receive the experimental cell therapy, and researchers will monitor side effects and wheth…
Early phase 1 • Sponsor: Mari Dallas • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Experimental T-Cell therapy targets CMV in transplant patients
Disease control Recruiting nowThis study tests an experimental therapy that uses special immune cells (T-cells) from a donor to fight cytomegalovirus (CMV) infection in people who have had a stem cell transplant. The therapy aims to boost the patient's immune system to clear the infection. About 20 participan…
Early phase 1 • Sponsor: Mari Dallas • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC